Nivolumab and Bevacizumab Combo Shows Activity in Ovarian Cancer

Combination therapy with nivolumab and bevacizumab appeared to have clinical activity in ovarian cancer patients with platinum-sensitive or platinum-resistant disease.

Source: CancerNetwork - October 18, 2019 Category: Cancer & Oncology Authors: Christina Bennett, MS Source Type: news